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ABSTRACT
Objective Chronic kidney disease (CKD) is often a 
multimorbid condition and progression to more severe 
disease is commonly associated with increased 
management requirements, including lifestyle change, 
more medication and greater clinician involvement. 
This study explored patients’ and kidney care team’s 
perspectives of the nature and extent of this workload 
(treatment burden) and factors that support capacity (the 
ability to manage health) for older individuals with CKD.
Design Qualitative semistructured interview and focus 
group study.
Setting and participants Adults (aged 60+) with 
predialysis CKD stages G3–5 (identified in two general 
practitioner surgeries and two renal clinics) and a 
multiprofessional secondary kidney care team in the UK.
Results 29 individuals and 10 kidney team members 
were recruited. Treatment burden themes were: (1) 
understanding CKD, its treatment and consequences, 
(2) adhering to treatments and management and (3) 
interacting with others (eg, clinicians) in the management 
of CKD. Capacity themes were: (1) personal attributes 
(eg, optimism, pragmatism), (2) support network (family/
friends, service providers), (3) financial capacity, 
environment (eg, geographical distance to unit) and life 
responsibilities (eg, caring for others). Patients reported 
poor provision of CKD information and lack of choice in 
treatment, whereas kidney care team members discussed 
health literacy issues. Patients reported having to withdraw 
from social activities and loss of employment due to CKD, 
which further impacted their capacity.
Conclusion Improved understanding of and measures 
to reduce the treatment burden (eg, clear information, 
simplified medication, joined up care, free parking) 
associated with CKD in individuals as well as assessment 
of their capacity and interventions to improve capacity 
(social care, psychological support) will likely improve 
patient experience and their engagement with kidney care 
services.
INTRODUCTION
Chronic kidney disease (CKD) affects approx-
imately 30% of individuals over 65 in the 
UK.1 2 Older individuals with CKD frequently 
have multiple long- term conditions, each 
requiring management such as arranging 
and attending appointments, having tests 
and taking medications.3–6 This demand 
and its impact on health and well- being has 
been called ‘treatment burden’.7–9 Individ-
uals with mild to moderate CKD (stages G1–
G3a) are usually managed in primary care 
in the UK and may experience more treat-
ment burden from comorbidities than from 
their CKD.4 10 Progression to stage G3b–G5 
may lead to new symptoms and new disease 
management requirements, including life-
style change, greater clinician involvement 
from multiple specialities and more frequent 
monitoring.11–13 Care demand from each 
condition interacts to increase workload on 
patients, potentially outweighing patient 
‘capacity’ (ie, their ability to manage work-
load created by both treatment/management 
regimens and the demands of everyday life) 
and risking treatment failure.7–9
Demands on patients who require renal 
replacement therapy (RRT) are well 
Strengths and limitations of this study
 ► Both patients’ and kidney care team members’ 
perspectives of treatment burden and capacity 
are explored to identify differences and areas for 
improvement.
 ► The study included patients from a range of socio-
economic status, geographical location and chronic 
kidney disease (CKD) severity stages recruited via 
both primary and secondary care to capture a broad 
range of perspectives.
 ► Primary care clinicians and other specialists in-
volved in the care of patients with CKD were not 
included in this study.
 ► Study participants were predominantly of white 
ethnicity.
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documented, but less is known for CKD not requiring 
RRT.14–17 Better understanding of patients’ and healthcare 
providers’ views on treatment burden, capacity and how 
these differ is needed to develop effective interventions, 
both at the individual care and at health system/service 
level.18–20 This is particularly important in the context of 
an ageing population: older people with CKD are more 
likely to experience greater burden of treatment due to 
existing comorbidities (eg, multiple medication, adverse 
drug effects), and may have reduced capacity to manage 
their conditions.4 17 We aimed to explore patients’ and 
kidney care team’s perspectives on the nature and experi-
ence of treatment burden and capacity for older individ-
uals with stages G3b–5 CKD, not currently requiring RRT.
METHODS
Participant selection
The reporting of this study is based on the Consolidated 
Criteria for Reporting Qualitative Health Research.21
Participants who were previously diagnosed with CKD 
(stages G3b–5) were recruited from two general practi-
tioner (GP) practices and two renal clinics in southern 
England. Participants recruited in primary care were 
identified through a search of GP practice lists for a 
coded diagnosis of CKD (estimated glomerular filtra-
tion rate (eGFR) <45) and then sent postal invitations to 
participate, from their GP. Participants recruited through 
secondary care were initially approached by local consul-
tant nephrologists (KA and KV) during attendance at 
routine renal outpatient clinics to establish interest in 
participating.
Participants were purposively sampled to allow diverse 
characteristics in terms of age, gender, comorbidities and 
residential area deprivation. Interested participants were 
screened for inclusion (aged 60+ with CKD stages G3b–5) 
and exclusion criteria (patients with terminal illness, 
those unable to give informed consent, and patients with 
CKD stage G5 due to start RRT in the next 3 months). 
Sample characteristics were monitored to ensure diversity.
A secondary care multiprofessional kidney team focus 
group was conducted in a large National Health Service 
(NHS) hospital trust that includes the local tertiary renal 
centre for a wide geographical area in southern England. 
Convenience sampling was used to identify and invite 
members for the focus group; KV and KA distributed 
the study information through local networks. Inclusion 
criterion was any health professional working as part of 
a kidney care team. We aimed to include representation 
from each main role (eg, nephrologists, pharmacists, 
administrator) within the core kidney care team. Exclu-
sion criteria included retired health professionals and 
health professionals that did not work with patients with 
CKD.
Data collection
All participants were given information sheets explaining 
the study aims. Written informed consent was obtained in 
the patient interviews and kidney team focus group. Inter-
viewers and facilitators were not known to patient inter-
viewees and kidney care team, respectively. Interviews with 
patients were chosen to explore individual experiences of 
CKD in depth, while a focus group discussion with health 
professionals was chosen to generate kidney care team’s 
views and understand areas of contention/consensus.
The interview guide explored how people manage 
their conditions and how they feel management impacts 
on daily living (box 1). The interview guide was reviewed 
by an experienced qualitative researcher (GL) and 
refined prior to the first interview and again after the first 
two interviews. HH (female researcher) and SF (male 
academic with past experience as a GP) conducted semi-
structured interviews. The interviews were conducted by 
telephone or face to face, at the participant’s home, to 
accommodate participant preference and lasted approx-
imately 1 hour.
The focus group topic guide explored the beliefs and 
experiences of professionals about treatment burden, its 
causes and associations (box 2). The guide was developed 
based on findings from the relevant literature and early 
findings from patient participant interviews and refined 
through discussions with GL. SF facilitated the kidney 
care team focus group. The focus group was conducted at 
participants' place of work (an NHS hospital) and lasted 
for 1 hour.
Box 1 Topic guide for patient interviews
Questions explored participants’ understanding of chronic kidney dis-
ease (CKD), CKD stage, comorbid conditions and treatment burden is-
sues. These included key potential drivers of burden identified from the 
existing literature, for example, the demands of medication, changes 
perceived to have arisen from CKD progression, general practitioner 
and hospital visits (renal and non- renal), the perceived burden of mak-
ing lifestyle changes according to advice, and the demands of self- 
management tasks (including monitoring blood pressure, eg). It also 
included questions on issues that may help ease the burden and en-
hance capacity, such as social support, better access to clear informa-
tion about how to manage their health and improved communication. 
Information about current support and facilitators and barriers to enable 
medication adherence and attendance at all scheduled appointments 
were explored in relation to perceived treatment burden. Basic demo-
graphic information, including age, education level, and marital status, 
was also recorded during interviews. Full interview guide is available in 
online supplemental appendix.
Box 2 Topic guide for focus group
The design of the focus group topic guide incorporated insights from 
the literature, early findings from patient interviews and questions to di-
rectly address the research question. Discussions included exploration 
of their perception of how people manage their conditions, the require-
ments of investigations, treatment and monitoring at different chronic 
kidney disease stages and views on factors that may optimise support 
for patients to help them manage identified burdens. Full topic guide is 
available in online supplemental appendix.
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Interviews and the focus group discussion were digi-
tally recorded and transcribed verbatim by a professional 
transcription company. Thematic analysis suggested satu-
ration had been reached by interview 26. Female partic-
ipants were recruited for a subsequent three interviews 
to achieve a better gender balance. Local nephrologists 
were also asked to introduce more patients from ethnic 
minority backgrounds to the study, although this did not 
result in an improvement in recruitment of non- white 
participants.
Data analysis
SF and HH undertook thematic analysis.22 Each transcript 
was read repeatedly and coded in detail, generating and 
reviewing a list of codes and themes. A draft coding frame 
was developed and agreed on by team members with qual-
itative expertise (GL and CM). NVivo V.12 software was 
used to organise codes and themes. Initial themes and 
subthemes were developed and refined through discus-
sion with the research team. It was identified retrospec-
tively that the findings fitted with the burden of treatment 
theory, which was then used to inform the analysis.8 Use 
of NVivo, sharing transcripts and group data discussions 
supported a systematic and transparent approach to 
working with data and ensured final themes were robust. 
Interviewers’ fieldwork notes were consulted during anal-
ysis to ensure the ‘live’ reflections captured during field-
work were available to analysts to aid final interpretations.
Interview transcripts and the focus group transcript 
were analysed separately. A table consisting of a list of 
themes and subthemes generated from interviews with 
patient participants was prepared. A similar table was 
prepared for the focus group discussion and compared 
with that of the interview.
Patient and public involvement
A patient with CKD was engaged throughout the project. 
At the application stage, the patient and public involve-
ment (PPI) representative provided advice on the plain 
English summary and other aspects of the research, such 
as consideration of variation between clinicians/units, 
the importance of adherence to treatments, the poten-
tial long period of time that people may spend predial-
ysis, the challenges of repeat prescriptions and changing 
prescriptions and the importance of the ethos/culture 
of clinical departments. Over the course of the study, he 
reviewed study materials such as information for patient 
participants, advised on draft interview guides and focus 
group topic guides, provided input on the interpretation 
of the findings and reviewed the manuscript. He is listed 
as a coauthor on the manuscript. Our PPI representative 
is similar to our study population in terms of age group, 
experience of CKD, geographical location.
RESULTS
Eleven patients were recruited from two primary care 
practices and 18 from two renal outpatient clinics. Mean 
age was 75 (range: 61–89). Most patients were of white 
ethnicity and CKD stage G3b or 4 (table 1). The focus 
group comprised two consultant nephrologists, four 
renal specialist nurses, two renal dieticians, one renal 
pharmacist and one multidisciplinary team coordinator 
and outpatient administrator. Focus group members were 
predominantly female (table 2).
Treatment burden
Treatment burden was interpreted as the work associ-
ated with negotiating healthcare and self- management of 
health could be understood through three intersecting 
themes: (1) understanding CKD, its treatment and conse-
quences, (2) adhering to treatments and management 
advice, (3) interacting with friends, family and health 
professionals. Table 3 compares subthemes from patient 
interviews and the focus group discussion. Illustrative 
Table 1 Characteristics of patient participants
N % of total*
Recruitment
  Primary care 11 38
  Secondary care 18 62
Sex
  Male 16 55
  Female 13 45
Age
  60–69 7 24
  70–79 13 45
  80–89 9 31
Ethnicity
  White 28 97
  Asian 1 3
Highest education attainment
  Secondary school 14 48
  Apprenticeship or other 
postsecondary school training
8 27
  Degree 7 25
Marital status
  Married 19 66
  Single 2 7
  Cohabiting partner 2 7
  Widowed 4 14
  Divorced 2 7
CKD stage
  3a 1 4
  3b 10 34
  4 12 41
  5 6 21
CKD, chronic kidney disease.
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quotations from patients and kidney team members are 
presented in the text.
Understanding CKD, its treatment and consequences
Some patients described feeling they were given insuffi-
cient information about CKD, even when they had asked 
for more information. Many were uncertain what they 
should be doing to manage their condition and felt that 
the coexistence of other conditions complicated this 
further.
I don't know whether you have to eat differently or 
whether you drink. I take an awful lot of tablets. So 
that’s probably what’s doing it, because I have high 
blood pressure. (Patient 16, female, CKD 5)
Others, particularly those recruited in secondary care, 
described the work of learning about the function of the 
kidneys and the investigations to check kidney function 
and outcomes of CKD. Many used the internet, leaflets 
and spoke with specialists to improve their understanding 
of CKD and its management, while a few relied only on 
what health professionals told them.
When I first got the kidney disease, I did look online a 
lot. For instance the kidney biopsy…I had the report 
and I looked up some of the things there to find out 
what they meant (Patient 17, female, CKD 3b)
Those who undertook self- directed research to gather 
information about CKD or spoke to specialists (eg, dieti-
cian) described challenges such as receiving conflicting 
advice.
They [Dieticians] sent me a list of foods which I 
shouldn't really have, because of the potassium lev-
els and acidic levels. But then I received a bigger 
pamphlet, and some of the things in it seemed to go 
against what the first pamphlet said. (Patient 9, male, 
CKD 5)
Some, mostly secondary care patients, were worried 
about their condition and future uncertainty. A few talked 
about planning for the future and wanting to be near a 
renal unit.
It’s not knowing what’s going to happen and every-
thing, it’s like a waiting game really (Patient 14, fe-
male, CKD 5)
Kidney team members also discussed issues with patients 
receiving conflicting advice from different clinicians and 
recognised the burden associated with the uncertainty 
of starting dialysis. However, some felt patients did not 
always appear to understand the aim or need for treat-
ment and investigations, particularly for earlier CKD 
stages when patients felt relatively well.
They need a basic understanding of what is going on. 
They fail to grasp the link between what we're trying 
to tell them about, what is likely to happen and why 
we're doing the—initiating the treatments and inves-
tigations we’re doing and everything else which can 
be, I think, very much muddied by their comorbidi-
ties and what other people have told them’
Loss of or inaccurate information for those not speaking 
English and attending clinics with friends or relatives to 
translate for them was highlighted.
The kind of different populations that we're seeing 
nowadays is growing. If we offer a Polish person an 
English language sheet, they’re like, ‘Oh!’ Just kind 
of do what you can with it and kind of get by with your 
basic interaction
Adhering to treatments and management
Many patients described the challenges of having to 
manage and attend many appointments (at different 
locations), and the time (specifically long waiting times) 
and effort (eg, arranging transport or difficulty parking).
I just get a bit fed up sometimes of all these visits. In 
the hospitals the people are wonderful, it’s just I’d 
like someone else to go instead of me. (Patient 20, 
male, CKD 3b)
Some patients reported challenges of having to take 
multiple medications, difficulty remembering drug 
names, or understanding which pills are for which condi-
tion, and practical difficulties with handling medication.
So I went into hospital, and when I came out, they 
gave me two carrier bags full of tablets, and I went to 
the doctor and I said, ‘I don’t want all these tablets.’ 
She said, ‘Well, if you don’t have them, Mrs *, you'll 
die.‘ So she said, ‘It’s up to you.’ So I just said, 'No, I 
prefer to take them then. (Patient 16, female, CKD 5)
I’m on umpteen pills a day. It seems like the medi-
cal profession are very good at saying, oh, take these, 
plonk, right. You take them, but nobody ever says, 
I think you're cured of that; you don’t need them 
Table 2 Characteristics of kidney care team members
N % of total*
Sex
  Male 1 10
  Female 9 90
Ethnicity
  White 10 100
Occupation
  Consultant nephrologist 2 20
  Renal specialist nurses 4 40
  Renal dieticians 2 20
  Renal pharmacist 1 10
  Multidisciplinary team coordinator/
outpatient administrator
1 10
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anymore. You just keep taking these pills, taking these 
pills, taking these pills (Patient 2, male, CKD 3b)
Some patients reported trouble keeping up with changes 
in medication and challenges filling prescriptions.
I have to go backwards and forwards between the chem-
ist and the doctors to try and get it sorted out. We just 
about got that sorted out, and then the manufacturer 
of the old tablets come back, so I got some of the tablets 
that he added plus the new ones that come back on 
the market. Then I have to dispose of these old tablets, 
otherwise I get mixed up. (Patient 20, male, CKD 3b)
Many patients, particularly those with CKD stage G4/5, 
described the difficulties of lifestyle changes, including 
dietary changes, avoiding certain medications, drinking 
adequate amounts of water, reducing alcohol and 
adopting low potassium diets.
Table 3 Components of treatment burden reported by patients and kidney care team members
Patients Professionals
Treatment burden Understanding CKD, 
its treatment and 
consequences
Given inadequate information to manage 
condition
Health literacy issues, language barriers
Information gathering Perceived lack of benefit in medications
Conflicting advice Conflicting advice
Anxiety/uncertainty about future Anxiety/uncertainty about future
Multimorbidity and polypharmacy adding 
complexity





Appointments Making note/keeping track of multiple 
appointments
Making note/keeping track of multiple 
appointments
Travel to appointments/no local care Travel to appointments/no local care
Parking Parking
Long waiting times Long waiting times
Wasted time and effort Wasted time and effort
Medication Lack of choice/lack of medication review
Remembering names of or distinguishing 
medications
Remembering names of or distinguishing 
medications
Practical difficulties with handling medication Practical difficulties with taking medication
Keeping up with changing medication
Challenges filling prescriptions
Multimorbidity and polypharmacy adding 
complexity




Difficulty obtaining GP appointments Difficulty obtaining GP appointments
Short appointment lengths
Unexpected changes to healthcare (eg, being 
taken off dialysis list)
Lack of interpersonal continuity of care Lack of interpersonal continuity of care
Communication barriers with health professionals Communication barriers with health 
professionals
Lack of communication and coordination 
between primary and secondary care
Lack of communication and coordination between 
specialists
Lack of communication and coordination 
between specialists
    Lack of standardised procedures (eg, 
different blood forms)
*Differences in perspectives highlighted in bold.
CKD, chronic kidney disease; GP, general practitioner.
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I’m supposed to drink eight pints a day for the kidneys 
which is very difficult, and when you’ve got a bladder 
that doesn’t hang on, it’s very awkward. (Patient 28, 
female, CKD 4/5)
I could not take anything really because of my kid-
neys. I had been told by a kidney specialist at the 
hospital that the only thing I could take for pain was 
paracetamol. (Patient 5, female, CKD 3b)
Kidney team members generally agreed with patients’ 
reports regarding travel and burden of medication, 
and long waiting times associated with patient transport 
services. Multiple members noted the need for more 
clarity in written communication to patients (eg, clarifica-
tion of appointment location).
They might have had an hour appointment…and 
had about a six- hour day.
We see patients throughout the region and they travel 
up here for various appointments and that is a big thing 
because they can't understand why they can’t have it all 
done in one place…or on the same day
Interacting with others
Most patients described difficulties obtaining appoint-
ments with GPs and the short appointment lengths.
I phone up for an appointment, I held it for 10 min-
utes and I thought this is enough. Then I dialled, 
held for 10 minutes, another 10 minutes. The last 
time I did it I rung and I was put straight onto hold 
and so three min nobody answered put it down. Six 
times I’ve done that in a day, one day. (Patient 6, fe-
male, CKD 4)
The lack of interpersonal continuity of GP care was 
highlighted by many. Patients frequently reported seeing 
a different GP every time and having to explain their 
health each time.
The GP- because you see a different one every single 
time- they don't know you from a bar of soap (Patient 
8, female, CKD 3b)
Some patients reported communication issues with 
doctors and nurses including poor bedside manner and 
difficulties understanding the doctor. Some patients 
reported lack of communication and coordination 
between primary and secondary care, and between 
hospital specialists.
When I met [my nephrologist], she actually said—
‘why didn’t they contact the renal team here? …so 
we could have a joint discussion about what they were 
proposing and the pros and cons of their treatment 
recommendation vs what we think you've got on the 
renal side?’ That’s not joined up. (Patient 11, male, 
CKD 3a)
The kidney team discussed the importance of regular, 
effective communication and building trust to encourage 
treatment adherence. Disjointed electronic systems, poor 
communication between specialties and lack of standard-
ised communication procedures/forms between hospi-
tals were identified as barriers.
They struggle to get that balance right sometimes—
which comes down to the communication. It’s mak-
ing sure you’ve got that regular contact to sort of 
relieve the anxiety.
We spend a lot of time saying, ‘This is important, 
this is important, this is important' and then they’re 
getting admitted to [ X hospital], and they don't give 
it [erythropoietin] and they think, well, I’ve been 
told this is really important and that causes anxiety
Patient capacity
We categorised experienced capacity in three ways: (1) 
personal attributes/attitudes, (2) support network, (3) 
financial capacity, environment and life responsibili-
ties. Table 4 presents subthemes of capacity, reported by 
patients and the kidney team. Illustrative quotations from 
patients and kidney team members are presented in the 
text.
Personal attributes/attitudes
Some patients described trying to remain positive.
I just sort of try and remain positive…You’ve got to 
try and look on the bright side no matter what’s hap-
pening.’ (Patient 4, female, CKD 4)
Many patients reported using organisational skills such 
as keeping diaries and developing routines to remind 
when to take medication or attend appointments.
It’s just habit, I know I take so many tablets in the 
morning, another one at lunch time and the others 
in the evening before I go to bed, it’s just a routine. 
(Patient 27, female, CKD 4)
Some reported setting exercise targets or monitoring 
their own blood pressure. Some reported using the 
internet to gather information about their condition, 
email health professionals, view results, and book GP 
appointments.
The kidney team also recognised the importance of a 
positive patient attitude in terms of how they managed 
their CKD.
It’s the glass half- full people who are always look-
ing…'Yes, okay, this is bad but I'm going to manage it
The kidney team also mentioned other important 
factors including socioeconomic status, educational 
level and CKD severity. Specifically, they noted that 
patients from lower socioeconomic background experi-
enced more difficulty managing their condition whereas 
patients of higher socioeconomic status with the same 
conditions found if easier or seemed to have better knowl-
edge of how to access services. Patients with greater CKD 
severity appeared to have a better understanding of CKD 
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and greater belief in treatments, as opposed to patients 
with early stages of CKD, who may not have symptoms and 
therefore may be less likely to see the value in treatments.
Support network
Many patients reported family members and friends 
helped with practical issues around disease management, 
such as cooking, shopping and reminding about, driving 
to and attending appointments with them. Men, in partic-
ular, spoke of the value of having their partner present, 
including attending appointments and listening to the 
doctors with them to help them better understand what 
they needed to do to manage their health.
That’s quite useful, because when two people hear 
the story [what the clinician has said during the ap-
pointment] and then you talk about it afterwards, you 
pick up things that you might have missed (Patient 
18, male, CKD 4)
A few chose not to burden their family, and more specif-
ically children, with their conditions.
I've managed to hide it from my daughter. I wouldn’t 
like my daughter to know, she knows very little about 
what has happened to me…she’s a real worrier. 
(Patient 20, male, CKD 3b)
Two patients highlighted the need for more ‘disease 
community’ groups connecting people with the same 
condition.
Many reported having to adopt a slower pace of life 
and limiting activities such as gardening, travel or social 
engagements.




Trying to be positive/focusing on the positives Having a positive attitude
Demographic characteristics: Level of 
education, socioeconomic background
Pragmatic skills: internet use, emailing health 
professionals, routinising life, setting targets, 
monitoring blood pressure
Engaging with health professionals 
and research
Support network Family and friends that give emotional and 
practical support (transport, food, getting 
medication, health literacy) and motivation
Family and friends that give emotional 
and practical support
Restricted social activities due to burden of 
CKD
Carer support
Patient transport services Patient transport services
Patient groups and community support 
(including 'disease community')
Specialist input (psychologists, social 
services)
Exercise club
Information sources: clinicians, leaflets, 'patient 
view'






Financial struggles: loss of employment, limited 
benefits
Financial struggles: time off work, costs 
associated with lifestyle changes (eg, 
diet), loss of employment
Car ownership/ ability to pay for transport to 
appointments, private treatment
Geographical location: being close to hospitals Geographical location: being close to 
hospitals
Blue badge for disability
Adaptations to home
Buying equipment to help manage conditions (eg, 
pain)
  Carers of dependants Carers of dependants
CKD, chronic kidney disease.
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I have stopped helping with the lunches because I’ve 
found that my kidney complaint is making me very, 
very tired, so I've decided that I’ve just got to look 
after myself (Patient 29, female, CKD 5)
Kidney team members generally agreed with patients’ 
reports. Administration staff were identified as an impor-
tant source of support (taking phone calls, booking suit-
able appointments, maintaining a friendly atmosphere). 
Many members discussed the lack of mental health and 
social services and their potential importance for people 
with CKD.
Patients ask about specialist input in terms of levels 
of activity and exercise. They want special advice, psy-
chology. Social workers
Financial capacity, environment and life responsibilities
Patients were receiving free care under the NHS. 
However, some reported paying for private care (eg, for 
pain management) to avoid long waiting times or buying 
expensive equipment to help manage pain.
It’s a lot of money but I can afford to have it done. 
There are people who aren't as well off as I am who 
can’t… I can’t imagine being in that situation. That’s 
no choice at all. You’re stuck with waiting what will 
have been almost a year to get the treatment [radiof-
requency ablation]. (Patient 22, male, CKD 3b)
Two patients lost employment due to symptom burden 
and received limited financial support. Some discussed 
the cost of travel to appointments, and how living nearby, 
owning a car or having patient transport services helped 
with this.
Well there’s poor and there’s rich and they've got cars 
and go there [hospital] on their own. But as I say, if 
you haven't got it you can't do it can you? (Patient 6, 
female, CKD 4)
In addition to managing their health, some patients 
reported the impact of other life responsibilities such as 
working and being a carer for family members.
I’ve spent the last week being online, getting num-
bers, phoning Fit for Work to see what we can and 
can’t do, phoning—just trying to sort my husband 
and Granny’s appointments, and bathing granny and 
doing all her washing and our washing. (Patient 8, 
female, CKD 3b)
Kidney team members acknowledged that caring 
responsibilities further increased burden and influenced 
treatment decision. It was agreed that attending appoint-
ments, symptom burden, and dietary requirements 
contributed to financial difficulties.
I think they worry about their health and how they’re 
going to be able to live a life as they have previously 
done, working, financial commitments, family com-
mitments. They all play a massive part
DISCUSSION
This study explored patients’ and kidney care team’s 
views on the nature and experience of treatment burden 
and patient capacity for older patients with predialysis 
CKD. Both patients and kidney team members discussed 
how patient factors (eg, presence of comorbidities) and 
healthcare system factors (eg, multiple appointments, 
communication and coordination issues between hospi-
tals/specialties) influenced treatment burden, which 
is consistent with the previous literature.14 23 Both 
groups considered patient capacity as being dependent 
on psychological, social and financial/environmental 
factors, and interacting with treatment burden.
There were some differences in views of treatment 
burden and capacity according to patient characteris-
tics. Female patients generally appeared to have a better 
understanding of their renal function and how to manage 
their health than males. Travel and time spent at appoint-
ments and not being able to enjoy hobbies due to their 
health seemed to be a greater burden for males. Females 
used humour and also appeared to make use of a wider 
support network (children, grandchildren, clinicians) to 
help them manage their condition, while males relied on 
their spouses. Travel to appointments and keeping track 
of multiple appointments was particularly burdensome 
for single patients (both males and females). Patients 
aged 60–79 were more likely to discuss being able to stay 
positive and appeared more likely to self- monitor, whereas 
older patients appeared to rely more on their clinicians 
and did little additional research to find out more about 
their conditions. Highly educated patients in particular 
flagged healthcare organisation issues such as fragmented 
care and poor communication and coordination between 
clinicians, but they appeared more able to express their 
needs with clinicians and were more involved in decisions 
regarding their care than patients with lower education 
levels. Highly educated patients as well as patients with 
greater CKD severity depended more on nephrologist for 
information and advice. In addition to appointment and 
travel burden, patients with greater CKD severity (CKD 4 
or 5) were more likely to discuss complexity with medi-
cation such as drug interactions with other medications 
for other conditions as well as changing or conflicting 
information from clinicians than patients with CKD stage 
3. Location of hospital was a challenge for rural patients 
and patients from lower socioeconomic background, 
though many rural patients were able to drive and some 
also able to choose their hospital. There were no appre-
ciable differences in views of patients recruited from 
primary and secondary care.
There were differences in perspectives on the extent 
to which healthcare service and system- level factors influ-
enced treatment burden. Patients attributed poor under-
standing of CKD and its treatment to poor provision of CKD 
information, whereas kidney care team members tended 
to focus on patients’ health literacy levels. This finding is 
in line with the literature suggesting how, by whom and 
at what point self- care information is provided determine 
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how well patients may engage with and used the informa-
tion.24 Patients often expressed lack of choice and control 
over their management: (eg, having no choice but to take 
medication, wait for treatment, unexpectedly being taken 
off transplant list), suggesting suboptimal communication 
between patients and clinicians and lack of shared deci-
sion making. This highlights the importance of involving 
patients in their care and the need for good patient–clini-
cian relationship and effective communication as well as 
consideration of what is truly best for the patient.25 While 
clinicians need to acknowledge that patients’ interest in 
engaging in decision making, patients also need to be feel 
they have the knowledge, skills and confidence to make 
important health decisions.26 Another difference was the 
extent to which treatment burden was perceived to impact 
on daily life—patients described being forced to withdraw 
from social activities, which was not noted by kidney care 
members. This withdrawal may result in isolation, particu-
larly for those living alone. Some also chose not to burden 
family members with the management of their condition. 
These patients are a vulnerable group as social isolation 
has been associated with reduced self- efficacy to manage 
health.27 Some of the discrepancies between patient and 
kidney care team perspectives may also have been due to 
the inclusion of healthcare professionals with a key role in 
CKD care, rather than broader healthcare specialists such 
as physiotherapists.
Our findings are consistent with the Cumulative 
Complexity Model which posits that the impact of treat-
ment burden is dependent on each person’s dynamic 
context, as well as the Burden of Treatment Theory which 
proposes that treatment burden influences the extent 
to which patients can engage in their healthcare and 
everyday responsibilities and relationships.7 8 Our study 
findings are in line with a UK study among patients with 
CKD stage 4 exploring experiences of adopting recom-
mended life style changes and showing that patients felt 
guilty about being a burden to others, difficulties with 
adherence and uncertainty over treatment plans.12 One 
US study explored treatment burden in a low income, 
predominantly African- American community and identi-
fied four similar treatment burden themes to our study.28 
Previous international studies have identified variation in 
patients’ understanding of CKD and a need for more CKD 
information and psychological support for people diag-
nosed with CKD and that acceptance, adopting a positive 
attitude and problem- solving were successful coping strat-
egies that predialysis CKD patients adopted to successfully 
manage their health.10 29 Similar themes have also been 
reported in other conditions.30–32 However, life context 
and biography will shape how realistic coping strategies 
of positivity and problem solving are. The current study 
extends previous findings by bringing together patients’ 
and healthcare professionals’ views of treatment burden 
and capacity and highlighting important differences in 
perspectives of the two groups.
Strengths of the study were the inclusion of patients 
from a range of socioeconomic status, geographical 
location and CKD severity stages. Furthermore, this study 
recruited via both primary care and secondary care, to 
capture perspectives of those less burdened and as much 
of CKD management occurs in primary care in the UK. 
The study also explored both treatment burden and 
capacity and views of both patients and a kidney team, 
allowing a more complete understanding. A limitation 
was the lack of input from primary care clinicians, as well 
as other specialties (eg, endocrinologists, cardiologists) 
with a key role in CKD care, which may have resulted in 
additional themes. However, previous studies exploring 
GP’s views on the management of CKD in primary care 
have identified similar themes including barriers to 
understanding CKD and its treatment and anxiety over 
future consequences and medical factors.33–35 Another 
limitation is participants being predominantly of white 
ethnicity meaning that it was not possible to examine the 
influence of ethnicity on treatment burden and capacity. 
The study was conducted in an area with predominantly 
white residents and the small proportion of non- white 
participants in our study is similar that of the area popula-
tion. Finally, patients who agreed to participate might be 
more engaged or systematically different (eg, healthier, 
from less socioeconomically deprived areas) from those 
who declined to take part.
This study highlights the importance of the patient 
perspective, and the need for clinicians’ understanding 
and availability to discuss the intersecting pressures, 
socioeconomic issues and comorbidities that patients 
experience. Careful assessment and improved documen-
tation of individual patient capacity issues can help clini-
cians understand the extent to which patients can cope 
and develop more suitable treatment plans that meet 
patients’ need.36 Specific supporting services and better 
signposting (including sources of psychosocial support 
such as disease community, and sources of information on 
disability benefits, subsidised access to parking) can help 
improve the social care, psychological and financial needs 
that may make it difficult for patients to cope with their 
conditions. Better communication between healthcare 
professionals and patients allows opportunities for ques-
tions about CKD and enhances patient confidence.37 38 
While some treatment burden is inevitable, a degree may 
be lessened if comorbidities are adequately considered. 
Improved understanding and consideration of all the 
work patients need to do to follow treatment recommen-
dations for each of their different conditions highlights 
the need for co- ordinated care among health specialists 
in order to reduce contradictory advice, fragmented care 
and unnecessary medication and appointments. Clini-
cians may need to adopt a pragmatic approach to care 
when developing management plans together with other 
health professionals.39 The use of integrated systems 
can allow better communication between specialties 
(and between secondary, primary and social care). Both 
patients and healthcare professionals noted poor coordi-
nation of care. This may at least partly be because there is 
sometimes lack of clarity about who is the key coordinator 
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of care for people with CKD for example, GP or nephrolo-
gist. This is particularly true because patients seldom have 
CKD in isolation and often have other long- term condi-
tions, so for some, for example, people with diabetes, 
they may even regard another hospital specialist as their 
main coordinator of care. In addition, with changes in 
primary care, there is often lack of continuity, that is, not 
seeing the same GP. The GP might previously have always 
been regarded as the central point of contact/care coor-
dination for people. Therefore, clarity on the identity of 
the care coordinator may be needed to avoid confusion 
and ensure management plans are designed to take into 
account other long- term conditions.40 Shared access to 
data and adequate facilities and training can also allow 
‘virtual’ specialist consultation, which may be needed post- 
COVID-19 but also may reduce burden (while acknowl-
edging the challenges of this for some patients).41 There 
is some evidence to suggest virtual consultations may be 
associated with fewer unnecessary appointments, and 
increased engagement in care for patients with long term 
conditions.42 Navigator programmes may also improve 
quality and process of care through addressing patient’s 
individual needs and helping them overcome barriers to 
care. Evaluation of such programmes is underway, though 
studies have not focused specifically on a UK CKD popu-
lation.43 44
CONCLUSION
Improved understanding of and measures to reduce the 
treatment burden (eg, clear information, simplified (easy 
to follow guides explaining the medication and medica-
tion schedule) and appropriate medication, joined up 
care, free parking) associated with CKD in individuals as 
well as assessment of their capacity, better signposting to 
supporting services (disease community, financial bene-
fits) and interventions to improve capacity (social care, 
psychological support) will likely improve patient expe-
rience and their engagement with kidney care services.
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